Genomic Health, Inc.
Genomic Health Announces Publication of Data Demonstrating that the Oncotype DX Breast Cancer Test Significantly Influences Breast Cancer Treatment Decisions, While Increasing Physician Confidence and Patient Satisfaction
Published in Women's Health Weekly, January 28th, 2010
Genomic Health, Inc. (NASDAQ:GHDX) announced the publication of a prospective, multi-center, study that showed the Oncotype DX® breast cancer test Recurrence Score® had a significant impact on breast cancer treatment decisions for early-stage breast cancer patients while increasing patient satisfaction and physician confidence in those decisions. The study found that knowledge of a patient's Recurrence Score changed oncologists' treatment recommendations in 31.5 percent of cases and changed 27 percent of breast cancer patients' treatment decisions. The study was published online on Monday in the Journal of Clinical Oncology.
The Oncotype DX breast cancer test...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- University of Pittsburgh Schools of the Health Sciences
Dementia linked to high blood pressure years earlier - Antisense Technology
Researchers at University of Nottingham publish new data on antisense technology - Bacterial Vaginosis
Researchers from University of North Carolina provide details of new studies and findings in the area of bacterial vaginosis - Bioengineering
Reports from University Medical Center advance knowledge in bioengineering - Bioengineering
Research from University of Texas broadens understanding of bioengineering - Bioengineering
Studies from University of Toronto reveal new findings on bioengineering - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
